Skip to main content
TipRanks
Go Ultimate75% OFF

Dongsung Pharmaceutical Co., Ltd. (002210) Ratios

Dongsung Pharmaceutical Co., Ltd. Ratios

KR:002210's free cash flow for Q2 2026 was ₩-20.04B. For the 2026 fiscal year, KR:002210's free cash flow was decreased by ₩-496.90M and operating cash flow was ₩-19.54B. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.690.881.361.141.33
Quick Ratio0.540.590.920.830.92
Cash Ratio0.030.040.140.090.08
Solvency Ratio-0.16-0.06-0.00-0.00-0.04
Operating Cash Flow Ratio-0.10-0.13-0.10-0.08-0.07
Short-Term Operating Cash Flow Coverage-0.20-0.19-0.17-0.13-0.14
Net Current Asset Value₩ -56.18B₩ -28.58B₩ -14.36B₩ -10.50B₩ -8.16B
Leverage Ratios
Debt-to-Assets Ratio0.380.340.380.340.28
Debt-to-Equity Ratio2.740.941.090.870.63
Debt-to-Capital Ratio0.730.490.520.460.39
Long-Term Debt-to-Capital Ratio0.000.010.320.150.17
Financial Leverage Ratio7.212.752.892.522.25
Debt Service Coverage Ratio-0.24-0.030.080.04-0.08
Interest Coverage Ratio-2.35-1.760.27-1.56-7.44
Debt to Market Cap2.880.490.320.240.15
Interest Debt Per Share3231.022441.691990.461666.841284.66
Net Debt to EBITDA-2.91-23.8810.7721.57-15.13
Profitability Margins
Gross Profit Margin41.71%43.96%46.70%45.06%39.74%
EBIT Margin-26.23%-4.43%1.55%-0.58%-4.34%
EBITDA Margin-23.78%-2.32%3.86%1.64%-2.05%
Operating Profit Margin-26.23%-7.45%0.67%-2.19%-6.28%
Pretax Profit Margin-32.91%-8.66%-0.98%-1.98%-5.19%
Net Profit Margin-29.53%-8.20%-2.34%-2.27%-5.11%
Continuous Operations Profit Margin-29.53%-8.20%-2.34%-2.27%-5.11%
Net Income Per EBT89.71%94.74%239.51%114.65%98.48%
EBT Per EBIT125.46%116.12%-145.18%90.64%82.64%
Return on Assets (ROA)-15.28%-4.77%-1.80%-1.97%-4.12%
Return on Equity (ROE)-110.12%-13.14%-5.21%-4.96%-9.29%
Return on Capital Employed (ROCE)-59.02%-8.81%0.85%-3.40%-7.91%
Return on Invested Capital (ROIC)-19.94%-4.94%0.63%-2.28%-6.02%
Return on Tangible Assets-15.32%-4.80%-1.82%-1.99%-4.16%
Earnings Yield-115.68%-6.85%-1.54%-1.38%-2.20%
Efficiency Ratios
Receivables Turnover4.012.462.832.823.03
Payables Turnover4.394.144.195.167.42
Inventory Turnover2.612.182.423.433.28
Fixed Asset Turnover1.211.202.072.122.26
Asset Turnover0.520.580.770.870.81
Working Capital Turnover Ratio-3.5124.957.789.714.68
Cash Conversion Cycle147.63227.83192.42164.96182.80
Days of Sales Outstanding90.94148.51128.92129.38120.66
Days of Inventory Outstanding139.88167.46150.54106.31111.36
Days of Payables Outstanding83.1988.1387.0470.7449.22
Operating Cycle230.83315.96279.46235.69232.02
Cash Flow Ratios
Operating Cash Flow Per Share-562.42-434.84-187.76-168.78-117.72
Free Cash Flow Per Share-619.10-542.71-228.15-196.73-217.13
Dividend Paid and CapEx Coverage Ratio-9.92-4.03-4.65-6.04-1.18
Capital Expenditure Coverage Ratio-9.92-4.03-4.65-6.04-1.18
Operating Cash Flow Coverage Ratio-0.20-0.19-0.10-0.10-0.09
Operating Cash Flow to Sales Ratio-0.15-0.11-0.05-0.04-0.03
Free Cash Flow Yield-63.63%-11.72%-3.87%-2.94%-2.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.86-14.58-65.05-72.64-45.42
Price-to-Sales (P/S) Ratio0.261.201.521.652.32
Price-to-Book (P/B) Ratio0.951.923.393.604.22
Price-to-Free Cash Flow (P/FCF) Ratio-1.57-8.53-25.86-34.06-38.59
Price-to-Operating Cash Flow Ratio-1.73-10.65-31.42-39.70-71.19
Price-to-Earnings Growth (PEG) Ratio-0.00-0.0639.211.450.66
Enterprise Value Multiple-3.98-75.5250.20122.50-128.32
Enterprise Value82.52B154.82B171.75B187.07B222.04B
EV to EBITDA-3.98-75.5250.20122.50-128.32
EV to Sales0.951.751.942.002.63
EV to Free Cash Flow-5.83-12.48-32.92-41.34-43.75
EV to Operating Cash Flow-6.42-15.57-40.00-48.18-80.70
Tangible Book Value Per Share1000.892383.961697.871823.761946.56
Shareholders’ Equity Per Share1022.082413.111740.681860.971986.89
Tax and Other Ratios
Effective Tax Rate0.100.05-1.40-0.150.02
Revenue Per Share3812.163868.113874.474057.083611.27
Net Income Per Share-1125.56-317.20-90.70-92.23-184.52
Tax Burden0.900.952.401.150.98
Interest Burden1.251.96-0.633.411.19
Research & Development to Revenue0.040.050.050.040.04
SG&A to Revenue0.630.310.300.310.27
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.501.372.071.830.64

Currency in KRW